Back

Sex differences in the incidence of appropriate ventricular arrhythmias therapy in patients with ICD or CRT-D for primary prevention

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Women's cardiovascular disease and pregnancy Cardiovascular Disease in Women ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Julien Lopes

Hospital de Santa Marta, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail
Risks of antihypertensive treatment use in different periods of pregnancy
Professor J. Vaclavik (Ostrava, CZ)
Abstract Slides Video
Presentation thumbnail
Risk factors and prediction model for hypertension in women with hyperandrogenic phenotypes of polycystic ovary syndrome
Doctor A. Stevanovic (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Empagliflozin significantly reduces the capacity of sera to induce endothelial dysfunction in Ischemia Non-Obstructive Coronary Arteries (INOCA): EMbArk phase II pilot trial
Doctor O. Quesada (Cincinnati, US)
Abstract Slides Video
Presentation thumbnail
Sex differences in trajectory of left ventricular reverse remodelling under contemporary GDMT in recent-onset dilated cardiomyopathy
Doctor Z. Yang (Chengdu - Sichuan, CN)
Abstract Slides Video
Presentation thumbnail
Improving hypertension management in Egyptian women through standardised nurse training on blood pressure measurement
Professor R. Hany Ibrahim (Cairo, EG)
Abstract Slides Video

Access the full session

Session thumbnail
Women's cardiovascular disease and pregnancy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Gender difference in life threatening arrhythmias in patients with non-ischaemic cardiomyopathy
thumbnail
Congress Presentation
Impact of gender on the utilisation implantable cardioverter defibrillators and outcome: results from the German DEVICE registry
thumbnail
Congress Presentation
Sex differences in shocks and device-related complications in subcutaneous implantable-cardioverter defibrillator patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources